Ethical and Social Impacts of Genomics and Genetic Engineering
Socio-Economic Impacts of Aging Populations
The Welsh Government is considering tax rises to address growing care costs for the elderly and disabled as the population of over- and over- increases.
Currently, the population of individuals aged over- in Wales consists of just under people.
The predicted cost for adult social care in Wales is expected to reach approximately .
Gene Editing and CRISPR Technologies
CRISPR/Cas9 technology allows for DNA editing in human embryos and has been used to modify genes associated with blood disorders and HIV resistance.
The first team to use CRISPR/Cas9 in human embryos to alter the gene causing a blood disorder was published in Protein & Cell on .
The Francis Crick Institute in the UK received a license for early-development research using CRISPR/Cas9 in human embryos.
The FDA approved Luxturna in as the first gene therapy for treating an inherited genetic mutation causing blindness.
Findings from Personal Genome Sequencing
The Personal Genome Project Canada released findings from its inaugural participants in .
One-quarter ( out of participants) possessed genetic variants associated with cancer, cardiovascular disease, or neurological disease.
of participants ( individuals) were at risk of life-threatening adverse drug reactions.
Direct-to-consumer (DTC) tests, such as AncestryDNA () and 23andMe, are criticised by experts for the risk of "false reassurance" or unnecessary anxiety without proper genetic counselling.
Ethical and Legal Challenges in Genomics
Cost disparities may lead to inequalities in healthcare, with for-profit "big pharma" providing limited incentives for addressing health problems in developing countries.
The deCODE project in Iceland utilised the nation's genetic homogeneity for gene isolation, leading to a $200\,\text{million} 1998.\n- A legal challenge by Ragnhildur Gudmundsdottir in 2003 resulted in an Icelandic Supreme Court ruling protecting her deceased father's medical records from the deCODE database based on privacy rights.\n\n# Informed Consent and Privacy Concerns\n\n- Informed consent in genetic research should meet international standards while remaining sensitive to local community practices, particularly in developing countries.\n- Genetic information is distinct because it involves entire families and can be used to predict future health, leading to potential discrimination in insurance or employment.\n- In certain cultural contexts, such as Aboriginal groups, genetic study is often treated as a community matter rather than solely an individual concern.\n\n# Behavioral Genetics and Stigmatization\n\n- The Nuffield Council on Bioethics highlights the need for public debate regarding research into how genes influence behavioral traits like aggression, intelligence, and sexual orientation.\n- Concerns exist regarding the CCR5 gene deletion performed by He Jiankui on the twins Lulu and Nana; while aimed at HIV resistance, the deletion is also linked to enhanced cognition and memory.\n- Genetic research can reveal unexpected data, such as misattributed paternity or unrevealed adoptions, causing undue stress to families.\n\n# Eugenics and Genetic Enhancement\n\n- Historical eugenics movements used racial or class prejudices to define "fit" and "unfit" individuals. \n- A 1937\frac{2}{3}63\% supported it for criminals.\n- Genetic enhancement of "all-purpose means" like memory or the immune system is debated as either a benefit or a tool for further social inequality.\n- "Gene doping" in sports is exemplified by the Finnish family with an EPO mutation that boosts red blood cell production, helping them win endurance sports championships.\n\n# Biohacking and DIY Biology\n\n- California passed the first law in the U.S. in 2019 to prevent genetic biohacking by restricting the sale of home gene therapy kits.\n- Biohacking ranges from self-prescribed pharmaceuticals for cognitive performance to installing cybernetic implants.\n\n# Questions & Discussion\n\n- Scenario: As an Ethics Review Board for a public hospital, should Pre-implantation Genetic Diagnosis (PGD) be permitted for the following?\n - To help two cystic fibrosis (CF) carriers avoid passing the disease to their child.\n - To help a couple produce umbilical cord cells for an existing child with Fanconi’s anemia (incidence rate: \frac{1}{350,000}$$ births).
To help a couple select the sex of their child for "family balancing."
To help a short couple produce a taller child.